BluePath Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$497K Buy
1,877
+877
+88% +$231K 0.26% 104
2026
Q2
$254K Buy
+1,000
New +$233K 0.14% 119
2024
Q2
– Sell
-1,402
Closed -$222K – 116
2024
Q1
$222K Sell
1,402
-5,314
-79% -$846K 0.17% 108
2023
Q4
$1.09M Buy
6,716
+1,104
+20% +$169K 0.93% 19
2023
Q3
$874K Buy
+5,612
New +$926K 0.8% 21

Other funds holding JNJ

BluePath Capital Management's JNJ Position: Q3 2026 in Review

BluePath Capital Management increased its Johnson & Johnson (JNJ) stake by 88% in Q3 2026, buying an estimated $231K and bringing the position to 1,877 shares worth $497K. The position accounts for 0.26% of the portfolio, ranked #104.

BluePath Capital Management first reported a position in JNJ in Q3 2023 and has held it in 5 quarters since. The position peaked at $1.09M in Q4 2023. 1,988 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • BluePath Capital Management held 1,877 shares of Johnson & Johnson worth $497K as of Q3 2026.
  • BluePath Capital Management bought 877 Johnson & Johnson shares in Q3 2026, an estimated $231K.
  • Johnson & Johnson made up 0.26% of BluePath Capital Management's portfolio in Q3 2026, its #104 holding.
  • BluePath Capital Management first reported a position in Johnson & Johnson in Q3 2023 and has held it in 5 quarters since.
  • BluePath Capital Management's Johnson & Johnson position peaked at $1.09M in Q4 2023.
  • 1,988 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on BluePath Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.